Clinical Operations experts from Palatin Technologies, Inc. (NYSE MKT: PTN) and
PHT Corporation will present on the effective use of eCOA Systems for clinical research on Female Sexual Dysfunction (FSD) at the Managing Data Summit which takes place December 4-5 in Philadelphia.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. PHT Corporation is the leading provider of patient-driven eData systems.
Presentation:Effective Use of eCOA in FSD: Best Practices and Study Design Recommendations
- Rob Jordan, Executive Director, Clinical Operations & Project Management, Palatin Technologies, Inc.
- Cheryl Van Walsh, Clinical Operations Project Manager, Palatin Technologies, Inc.
- Susan Dallabrida PhD, Director of Clinical Science and Consulting, PHT Corporation
Palatin Technologies, Inc. will review lessons learned and best practices for the successful implementation of an electronic clinical outcomes assessment (eCOA) System in Phase 2 Female Sexual Dysfunction. Palatin and PHT collaborated to devise a strategy to address the amount and complexity of patient-driven eData in a FSD trial. PHT will share strategies for the use of episodic and daily diaries and review findings on the frequency of sensitive information event capture electronically vs. paper PRO. The presenters also will examine the benefits of using an online reporting system for eligibility and tracking.
To hear other case studies, innovations and best practices about PROs and eCOA strategy and systems, register for the 2014 PRO & eCOA Congress at
. PHT invites all Congress alumni to join the exclusive
PRO & eCOA Congress LinkedIn Community
to exchange information, ideas and experiences throughout the year.
About PHT Corporation
PHT Corporation helps pharmaceutical companies and CROs conduct clinical trial programs with greater confidence, ease and accuracy. Proven PHT electronic clinical outcome assessment (eCOA) Systems collect patient-driven eData via smartphones, tablets and the web. This data, available via
online reporting portal, provides sponsors and clinicians with a real time window into how patients feel and function. PHT has helped trial sponsors collect patient-driven eData in 650+ global trials resulting in 16+ regulatory approvals. PHT Clinical Science and Consulting offers the scientific, regulatory, and technological expertise today’s eCOA market demands and patients deserve. Visit
for more information on PHT. Follow PHT on
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts